Hemophilia A&B

Package Deal

Update, November 2014: The St. Jude/UCL gene therapy trial now has data from all 10 participants, to be published in...

Novel Technologies, Hemophilia A&B

This year’s mandatory federal budget cuts, known as “the sequester,” have been raising concerns about the future of biomedical research...

Researcher Profiles, Hemophilia A&B

Research into treatments and cures for hemophilia takes place in laboratories all over the country. So it’s no wonder that...

Researcher Profiles, Hemophilia A&B

Cryoprecipitate. Long-acting factor concentrates. Gene therapy trials. These are just a few of the incredible clinical advances from the past...

Research & Treatment, Hemophilia A&B

During the past 20 years, advances in hemophilia treatment, including recombinant factor therapy, have allowed people with hemophilia to take...

Novel Technologies, Hemophilia A&B

As CEO of the National Hemophilia Foundation (NHF), I can honestly say this news has been decades in the making...

Research & Treatment, Hemophilia A&B

Editor’s Note: This article was funded through an educational grant from Novo Nordisk.

Research & Treatment, Hemophilia A&B

The marketing terms “new and improved” and “longer lasting” are not limited to the latest brand of chewing gum. They...

Novel Technologies, Hemophilia A&B, Rare Bleeding Disorders, Von Willebrand Disease

The same material that helps stop nasty nosebleeds also curtails cuts. In June 2011, NasalCEASE ®, an over-the-counter product manufactured...

Hemophilia A&B, Von Willebrand Disease

Alicia Unger is awake by 6:30 a.m. every day. She has only an hour or two to squeeze in a...

Hemophilia A&B, Family Matters

The “captain of the school army” had Dylan Edwards in his sights. He ordered his “soldiers” to chase Dylan, who...

Hemophilia A&B, Von Willebrand Disease, Taking Charge, Family Matters

Hidden veins. Worn-out veins. Blown veins. People with hemophilia who infuse factor products feel the frustration from uncooperative veins. One...

Hemophilia A&B